These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Therapeutic Effect of Plasmapheresis and Intravenous Immunoglobulin in Recipients of Kidney Transplant With High Panel-reactive Antibody Levels: A Single-center Experience. Sendogan DO; Saritas H; Kumru G; Erdogmus S; Tuzuner A; Keven K; Sengul S Transplant Proc; 2019 Sep; 51(7):2254-2256. PubMed ID: 31474291 [TBL] [Abstract][Full Text] [Related]
4. Perioperative Desensitization Improves Outcomes Among Crossmatch Positive Recipients of Deceased Donor Renal Transplants. Sharma A; King A; Kumar D; Behnke M; McDougan F; Kimball PM Prog Transplant; 2016 Jun; 26(2):157-61. PubMed ID: 27207404 [TBL] [Abstract][Full Text] [Related]
5. Successful kidney transplantation after desensitization using plasmapheresis, low-dose intravenous immunoglobulin, and rituximab in highly sensitized patients: a single-center experience. Jin MK; Cho JH; Kwon O; Hong KD; Choi JY; Yoon SH; Park SH; Kim YL; Kim CD Transplant Proc; 2012 Jan; 44(1):200-3. PubMed ID: 22310614 [TBL] [Abstract][Full Text] [Related]
6. Pre-transplant donor specific anti-HLA antibody is associated with antibody-mediated rejection, progressive graft dysfunction and patient death. Fidler SJ; Irish AB; Lim W; Ferrari P; Witt CS; Christiansen FT Transpl Immunol; 2013 Jun; 28(4):148-53. PubMed ID: 23665534 [TBL] [Abstract][Full Text] [Related]
8. Acute Antibody-Mediated Rejection in Kidney Transplant Based on the 2013 Banff Criteria: Single-Center Experience in Uruguay. Nin M; Coitiño R; Kurdian M; Orihuela L; Astesiano R; Garau M; López D; Rievas G; Rodriguez I; González-Martínez F; Noboa O Transplant Proc; 2016 Mar; 48(2):612-5. PubMed ID: 27110014 [TBL] [Abstract][Full Text] [Related]
9. Treatment of Biopsy-Proven Acute Antibody-Mediated Rejection Using Thymoglobulin (ATG) Monotherapy and a Combination of Rituximab, Intravenous Immunoglobulin, and Plasmapheresis: Lesson Learned from Primary Experience. Zheng J; Xue W; Qing X; Jing X; Hou J; Tian X; Guo Q; He X; Cai J Clin Transpl; 2014; ():223-30. PubMed ID: 26281149 [TBL] [Abstract][Full Text] [Related]
10. Desensitization with the Use of an Antibody Removal-Free Protocol in ABO-Incompatible Kidney Transplant Recipients with a Low Anti-A/B Antibody Titer. Nanmoku K; Shinzato T; Kubo T; Shimizu T; Kimura T; Yagisawa T Transplant Proc; 2018 May; 50(4):982-986. PubMed ID: 29731097 [TBL] [Abstract][Full Text] [Related]
11. Delayed Graft Function, Predictive Factors, and 7-Year Outcome of Deceased Donor Kidney Transplant Recipients With Different Immunologic Profiles. Quintella AHDS; Lasmar MF; Fabreti-Oliveira RA; Nascimento E Transplant Proc; 2018 Apr; 50(3):737-742. PubMed ID: 29661426 [TBL] [Abstract][Full Text] [Related]
12. Desensitization Before Living Donor Kidney Transplantation in Highly HLA-Sensitized Patients: A Single-Center Study. De Sousa-Amorim E; Revuelta I; Blasco M; Diekmann F; Cid J; Lozano M; Sánchez-Escuredo A; Martorell J; Palou E; Campistol JM; Oppenheimer F Transplant Proc; 2015 Oct; 47(8):2332-5. PubMed ID: 26518919 [TBL] [Abstract][Full Text] [Related]
14. Kidney transplantation across a positive crossmatch: a single-center experience. Santos C; Costa R; Malheiro J; Pedroso S; Almeida M; Martins LS; Dias L; Tafulo S; Henriques AC; Cabrita A Transplant Proc; 2014; 46(6):1705-9. PubMed ID: 25131017 [TBL] [Abstract][Full Text] [Related]
15. Effect of Preformed or De Novo Anti-HLA Antibodies on Function and Graft Survival in Kidney Transplant Recipients. de Sousa MV; Gonçalez AC; Zollner RL; Mazzali M Ann Transplant; 2018 Jul; 23():457-466. PubMed ID: 29976918 [TBL] [Abstract][Full Text] [Related]
16. Kidney transplant in highly sensitized patients after desensitization with plasmapheresis and low-dose intravenous immunoglobulin. Yuan XP; Wang CX; Gao W; Fu Q; He XS Exp Clin Transplant; 2010 Jun; 8(2):130-5. PubMed ID: 20565369 [TBL] [Abstract][Full Text] [Related]
17. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients. Meng HL; Jin XB; Li XT; Wang HW; Lü JJ Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748 [TBL] [Abstract][Full Text] [Related]
18. Preformed C1q-binding Donor-specific Anti-HLA Antibodies and Graft Function After Kidney Transplantation. Okabe Y; Noguchi H; Miyamoto K; Kaku K; Tsuchimoto A; Masutani K; Nakamura M Transplant Proc; 2018 Dec; 50(10):3460-3466. PubMed ID: 30577221 [TBL] [Abstract][Full Text] [Related]